RxDoctor Payments DataLook up a doctor →

Ryaltris: payments to doctors

Payments that named Ryaltris as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$285K
Providers
4,538
Transactions
8,770
Average per transaction
$33

The per-transaction average — $33 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,538 providers the average total is $63, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Hikma Pharmaceuticals USA$285,041100.0%
← All drugs & devices